The how, what and why of the latest HIV vaccine trial

Search This Blog: HIV MPOX

Deutsch — Español — Français — Italiano

The how, what and why of the latest HIV vaccine trial

South Africa Standard Time — Wednesday, November 02, 2016

The how, what and why of the latest HIV vaccine trial
- As the global quest for an HIV vaccine continues, Linda-Gail Bekker explains the significance of the latest large-scale trial underway in South Africa.

Being HIV-positive will no longer automatically disqualify police candidates in ...

South Africa Standard Time — Friday, March 29, 2024

Scientists Successfully Remove HIV From Infected Cells

South Africa Standard Time — Friday, March 22, 2024

COVID-19 impact on blood donor characteristics and seroprevalence of transfusion ...

South Africa Standard Time — Friday, April 05, 2024

Efforts to cure HIV

South Africa Standard Time — Wednesday, April 03, 2024

Egypt records first case of mpox

South Africa Standard Time — Friday, April 12, 2024

Stigmabase | HIV

The how, what and why of the latest HIV vaccine trial

Top stories of the last 30 days

Being HIV-positive will no longer automatically disqualify police candidates in ...

Scientists Successfully Remove HIV From Infected Cells

COVID-19 impact on blood donor characteristics and seroprevalence of transfusion ...

Efforts to cure HIV

Top 5 stories on co-morbidities affecting people with HIV from CROI 2024

Egypt records first case of mpox

Bictegravir, emtricitabine, and tenofovir alafenamide efficacy, safety in children with HIV 2 ...

India top in 40 countries in condom use adherence through sex workers